Alcidion Group Ltd (ASX: ALC) Share Price and News

Ms Wilson is an experienced company director with private, ASX listed and not-for-profit organisations. In her previous career, she held global leadership roles in marketing communication, investor relations, and corporate affairs. She has deep expertise in ESG, complex stakeholder communication, issues, crisis and risk management, transactions, and investor relations. She worked with multinational and growth companies in technology, healthcare, retail, and professional services sectors. Rebecca is experienced in leading companies during important commercial activation phases working with CEOs as both an advisor and non-executive director to develop and execute effective business strategy that supports accelerated and sustained growth. Rebecca is currently the Non-Executive Chair of AI-enabled technology company Clever Culture Systems Limited, and a Non-Executive Director of Hansen Technologies and Vitura Health Limited. She is a Non-Executive Director of NFP, The Tomisich Foundation and Veski. She is the chair of the Board.

Mr Smart is a digital health leader with over 30 years of experience leading transformational changes in organizations. Will has a track record of driving politically sensitive and operationally critical initiatives, enhancing organizational performance. Based in the United Kingdom, Will is currently Vice Chair of Aneurin Bevan University Health Board, Chair of the British Computer Society Faculty of Health and Care and was previously the CIO for Health and Social Care for England. In that role, Will provided advice to the Secretary of State for Health and Social Care and developed and delivered national strategies on information, technology and informatics. He has held executive roles in several NHS Trusts including as the Digital NED for Great Western Hospitals NHS FT, Group Chief Information Officer, Royal Free London NHS Foundation Trust. Will previously served as the Global Director of External Relations, Dedalus Group where he had responsibilities across the UK and Europe and led the launch of their European built Electronic Patient Record (EPR) solution into Ireland and the UK.

Ms Quirke has 25+ years of health sector experience and has been involved in procurements and implementations of healthcare information technology across Australia, New Zealand, the United Kingdom and South-East Asia. Her background includes leading management roles at healthcare software firms where she has driven strategic product direction, global sales and operations. She believes technology can enable the transformation of healthcare delivery. Kate is currently a Non-Executive Director of ANDHealth.

Mr Sharp has over 25 years of senior executive experience in investment banking and corporate finance. He was an Executive Director of Corporate Finance at Canaccord Genuity where he led dozens of equity capital market transactions and corporate finance advisory projects across the healthcare, life sciences, technologies, financial services and general industrials sectors. Prior to his executive role at Canaccord, Danny headed the corporate finance division at two leading independent Investment Banking/Stockbroking firms. Danny has managed the IPOs, capital raising and corporate advisory activities for many successful ASX listed companies in the healthcare, technologies and general industrials sectors. He is closely connected to networks of institutional, family office and net worth investors both in Australia and overseas. Danny is currently a Non-Executive Director of Botanix Pharmaceuticals and a member of the Investment Committee for the Baker Heart and Diabetes Institute Foundation.

Prof. Way commenced his career as a nurse in the UK National Health Service (NHS) and after a range of clinical positions, moved first into nursing leadership and then into general management. Andrew has held several senior executive roles hospitals in both the UK NHS and Australia. He has been a Chief Executive for nearly 25 years, recently as the CEO of Alfred Health in Melbourne, Victoria, finishing in 2024. Andrew has led several hospitals through major clinical and non-clinical digital transformations. Awarded an AM for his services in support of clinical research and leadership, he continues to advocate for integration of clinical research and clinical practice. Andrew is currently Board Chair of Latrobe Regional Health, Board Chair of HealthShare Victoria, a Director of Australian College of Health Service Management (ACHSM) and a Director of Melbourne Primary Care Network (MPCN). He continues to hold other health related advisory roles.

-

-

-